These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9284724)

  • 1. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure.
    Boguszewski CL; Jansson C; Boguszewski MC; Rosberg S; Carlsson B; Albertsson-Wikland K; Carlsson LM
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2944-9. PubMed ID: 9284724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.
    Boguszewski M; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2599-606. PubMed ID: 7673401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating non-22 kDa growth hormone isoforms in healthy children of normal stature: relation to height, body mass and pubertal development.
    Boguszewski CL; Jansson C; Boguszewski MC; Rosberg S; Wikland KA; Carlsson B; Carlsson LM
    Eur J Endocrinol; 1997 Sep; 137(3):246-53. PubMed ID: 9330588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.
    Ishikawa M; Yokoya S; Tachibana K; Hasegawa Y; Yasuda T; Tokuhiro E; Hashimoto Y; Tanaka T
    J Clin Endocrinol Metab; 1999 Jan; 84(1):98-104. PubMed ID: 9920068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating non-22 kDa growth hormone isoforms after a repeated GHRH stimulus in normal subjects.
    Coya R; Algorta J; Boguszewski CL; Vela A; Carlsson LM; Aniel-Quiroga A; Busturia MA; Martul P
    Growth Horm IGF Res; 2005 Apr; 15(2):123-9. PubMed ID: 15809015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery.
    Boguszewski CL; Johannsson G; Bengtsson BA; Johansson A; Carlsson B; Carlsson LM
    J Clin Endocrinol Metab; 1997 May; 82(5):1516-21. PubMed ID: 9141543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.
    Sas T; de Waal W; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age.
    van Pareren YK; Duivenvoorden HJ; Slijper FS; Koot HM; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5295-302. PubMed ID: 15531473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children born small-for-gestational age: postnatal growth and hormonal status.
    Albertsson-Wikland K; Boguszewski M; Karlberg J
    Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
    de Zegher F; Albertsson-Wikland K; Wollmann HA; Chatelain P; Chaussain JL; Löfström A; Jonsson B; Rosenfeld RG
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2816-21. PubMed ID: 10946888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.
    Carlsson LM; Attie KM; Compton PG; Vitangcol RV; Merimee TJ
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1325-30. PubMed ID: 8200933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.